Nexo And Injective Test Nerve As Price Compression Nears Breaking Point
Nexo and Injective have recently found themselves trapped in a tightening market squeeze, testing traders’ nerves as they navigate through a web of conflicting signals. With Nexo slipping around 5.5% this month and Injective caught in a downward drift, it’s clear the market’s mood has turned cautious. As both assets hover near pivotal levels, market…